{"disease":{"id":"ocular-hypertension-oht","name":"ocular hypertension oht"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02829996","title":"Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Inotek Pharmaceuticals Corporation","has_results":true},{"nct_id":"NCT06016972","title":"Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Qlaris Bio, Inc.","has_results":false},{"nct_id":"NCT06249152","title":"Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Qlaris Bio, Inc.","has_results":false},{"nct_id":"NCT05075226","title":"Visual Outcomes of Vivity in Patients With Well Controlled Glaucoma","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Maisonneuve-Rosemont Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}